Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China
Published: 6 January 2025| Version 1 | DOI: 10.17632/zjbcgr927x.1
Contributors:
yizhang liu, Kun Hu, Yongfang Duan, Xiang Chen, Mi Zhang, yehong kuangDescription
Supplementary Figure 1 illustrates the inclusion and exclusion criteria for psoriasis patients in this study. The univariable logistic regression analyses of patient characteristics associated with super-responders, as compared to non-super-responders, are presented in Supplementary Table 1. The results of univariable logistic regression analyses of patient characteristics associated with biologic-refractory patients, in comparison to non-biologic-refractory patients, are provided in Supplementary Table 2.
Files
Institutions
Xiangya Hospital Central South University
Categories
Biologic Agent, Psoriasis
Funders
- National Natural Science Foundation of ChinaChinaGrant ID: 82373484, 82073447, 82003354, 82221002, 82130090, 82003362